Cargando…
Flexible Modeling of Net Survival and Cure by AML Subtype and Age: A French Population-Based Study from FRANCIM
With improvements in acute myeloid leukemia (AML) diagnosis and treatment, more patients are surviving for longer periods. A French population of 9453 AML patients aged ≥15 years diagnosed from 1995 to 2015 was studied to quantify the proportion cured (P), time to cure (TTC) and median survival of p...
Autores principales: | Mounier, Morgane, Romain, Gaëlle, Callanan, Mary, Alla, Akoua Denise, Boussari, Olayidé, Maynadié, Marc, Colonna, Marc, Jooste, Valérie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069423/ https://www.ncbi.nlm.nih.gov/pubmed/33924506 http://dx.doi.org/10.3390/jcm10081657 |
Ejemplares similares
-
A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data
por: Botta, Laura, et al.
Publicado: (2023) -
Incidence and time trends of sarcoma (2000–2013): results from the French network of cancer registries (FRANCIM)
por: Amadeo, Brice, et al.
Publicado: (2020) -
The respective parts of incidence and lethality in socioeconomic differences in cancer mortality. An analysis of the French network Cancer registries (FRANCIM) data
por: Bryere, Joséphine, et al.
Publicado: (2019) -
Health care expenditures among long-term survivors of pediatric solid tumors: Results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM)
por: Bejarano-Quisoboni, Daniel, et al.
Publicado: (2022) -
Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer
por: Guilloteau, Adrien, et al.
Publicado: (2021)